V. L. Taylor

发表

Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons.

C. J. Schmidt, V. L. Taylor, Vicki L. Taylor, 1988, European journal of pharmacology.

Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.

C. J. Schmidt, V. L. Taylor, C. K. Black, 1990, European journal of pharmacology.

Comparison of Neurotensin Responses to MDL 100,907, a Selective 5HT2A Antagonist, with Clozapine and Haloperidol

C. J. Schmidt, G. Hanson, J. Gibb, 1997, Brain Research Bulletin.

Radical Trapping and Inhibition of Iron‐Dependent CNS Damage by Cyclic Nitrone Spin Traps

C. J. Schmidt, Craig E. Thomas, D. Ohlweiler, 1997, Journal of neurochemistry.

Characterisation of insulin-like growth factor-binding protein-3 binding to a novel receptor on human platelet membranes.

E. Spencer, V. L. Taylor, 2001, The Journal of endocrinology.

Singlet oxygen reactions in a glassy polystyrene matrix

R. Clough, R. Scurlock, P. Ogilby, 1998 .

A milk growth factor extract reduces chemotherapeutic drug toxicity in epithelial cells in vitro

L. Read, C. Goddard, V. L. Taylor, 2001, In Vitro Cellular & Developmental Biology - Animal.

Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.

C. J. Schmidt, V. L. Taylor, C. K. Black, 1990, The Journal of pharmacology and experimental therapeutics.

Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors.

C. J. Schmidt, V. L. Taylor, 1990, European journal of pharmacology.

Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.

C. J. Schmidt, V. L. Taylor, 1987, Biochemical pharmacology.

Photochemistry of cis-4,4-diphenyl-2-cyclohepten-1-one

E. M. Holt, R. Bunce, V. L. Taylor, 1991 .

The photochemistry of a two-carbon ortho-ortho phenyl-bridged 4,4-diphenyl-2-cyclohexen-1-one

E. M. Holt, R. Bunce, V. L. Taylor, 1992 .

Photochemistry of (±)-4,4a,5,6-tetrahydro-4a-methyl-6,6-diphenyl-2(3H)-naphthalenone, a rigid linear dienone

E. M. Holt, R. Bunce, V. L. Taylor, 1989 .

Amberlyst-15 Promoted Synthesis of Fused and Spiro γ-Butyrolactones from β-Hydroxyesters

R. Drumright, R. Bunce, V. L. Taylor, 1989 .

5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats

J. Kehne, C. J. Schmidt, V. L. Taylor, 1996, Psychopharmacology.

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine.

C. J. Schmidt, G M Fadayel, C K Sullivan, 1992, European journal of pharmacology.

The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.

C. J. Schmidt, T. Humphreys, S. Sorensen, 1992, European journal of pharmacology.

L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.

C. J. Schmidt, V. L. Taylor, C. K. Black, 1991, European journal of pharmacology.

Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.

J. Kehne, F. Salituro, B. Harrison, 1997, European journal of pharmacology.

Strychnine‐Sensitive, Glycine‐Induced Release of [3H]Norepinephrine from Rat Hippocampal Slices

C. J. Schmidt, V. L. Taylor, 1990, Journal of neurochemistry.

Neurochemical Effects of Methylenedioxymethamphetamine in the Rat: Acute Versus Long-Term Changes

C. J. Schmidt, V. L. Taylor, 1990 .

5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.

C. J. Schmidt, V. L. Taylor, T. Nieduzak, 1991, The Journal of pharmacology and experimental therapeutics.

Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors

C. J. Schmidt, V. L. Taylor, C. K. Black, 1990, Brain Research.

Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.

J. Kehne, C. J. Schmidt, V. L. Taylor, 1992, The Journal of pharmacology and experimental therapeutics.

Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.

J. Kehne, C. J. Schmidt, T. Humphreys, 1993, The Journal of pharmacology and experimental therapeutics.

Release of [3H]norepinephrine from rat hippocampal slices by N-methyl-D-aspartate: comparison of the inhibitory effects of Mg2+ and MK-801.

C. J. Schmidt, V. L. Taylor, 1988, European journal of pharmacology.

5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.

C. J. Schmidt, T. Humphreys, S. Sorensen, 1992, The Journal of pharmacology and experimental therapeutics.

Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methylenedioxymethamphetamine.

C. J. Schmidt, V. L. Taylor, C. K. Black, 1990, European journal of pharmacology.

Polymer characterization using singlet oxygen phosphorescence as a spectroscopic probe

R. Clough, M. Dillon, V. L. Taylor, 1991 .